Table 3

Drug therapy for children treated for MDR-TB who completed therapy (n=137)

DrugNumber of patients with drug included in regimen (%)Median duration of treatment in months (IQR)
Isoniazid (high-dose)136 (99.3)13 (11–18)
Rifampicin16 (11.7)7.5 (4.5–12)
Pyrazinamide136 (99.3)13.5 (11–18)
Ethambutol121 (88.3)12 (10–18)
Streptomycin2 (1.5)5.5 (4–7)
Amikacin82 (59.9)4 (3–6)
Capreomycin11 (8.0)4 (4–6)
Ofloxacin132 (96.4)13 (10.5–18)
Moxifloxacin2 (1.5)18 (17–19)
Ethionamide135 (98.5)13 (10–18)
Terizidone80 (58.4)17 (12–18.5)
PAS27 (19.7)17 (12–18)
Clarithromycin3 (2.2)12 (4–18)
Augmentin3 (2.2)18 (4–19)
Linezolid3 (2.2)16 (4–21)
  • MDR, multidrug-resistant; PAS, Para-aminosalicylic acid; TB, tuberculosis.